Research and Achievement*

Areas of Excellence

Dr. Mien-Chie Hung, Ph.DCurrent: VP at MD Anderson Cancer Center)
EZH2 promotes expansion of breast cancer tumor initiating cells through activation of RAF-b-catenin signaling
Cancer Cell 19(1):86-100, 2011.
【Full text】

Dr. Jer-Yuh Liu, Ph.D.

Protein Kinase C Alpha Expression in Human Hepatocellular Carcinoma.
Adaptive Medicine 3(1): 11-15, 2011.

【Full text】

Dr. Yung-Luen Yu, Ph.D.
 (Chair and Associate Professor)
EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling. J Biol Chem. 2011 Mar 18;286(11):9657-67.

                                       【Full text】

Dr. Chia-Ling Hsieh, Ph.D
Targeting L1 Cell Adhesion Molecule Using Lentivirus-Mediated Short Hairpin RNA Interference Reverses Aggressiveness of Oral Squamous Cell Carcinoma.
Mol Pharm, 7: 2312-23, 2010.
【Full text】

Dr. Jen-Liang Su, Ph.D.
FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Cancer Res. 2011 Nov
【Full text】

Dr. Long-Yuan Li, Ph.D
EZH2-mediated Epigenetic Regulation of Osteogenesis and Adipogenesis of Mesenchymal Stem Cells.
Nat Cell Biol
. 13(1):87-94, 2011;J Biol Chem. 286: 10671-10680, 2011

                【Full text 1】【Full text 2】

Dr. Wei-Chien Huang, Ph.D.
Nuclear translocation of EGFR by AKT-dependent phosphorylation enhances BCRP/ABCG2 expression in gefitinib-resistant cells.
J Biol Chem. 286(23):20558-20568

                           【Full text】

Dr. Shian-Ying Sung, Ph.D
Coevolution of prostate cancer and bone stroma in three-dimentional coculture: Implications for cancer growth and metastasis.
Cancer Research 68(23):9996-10003

                                          【Full text】

Dr. Wei-Chao Chang, Ph.D.
Observation of Peptide Differences between Cancer and Control in Gastric Juice
Proteomics Clin Appl. 2008 Jan;2(1):55-62.

                           【Full text】